Cargando…

Herpes zoster vaccine in Korea

Herpes zoster and post-herpetic neuralgia deteriorate the quality of life because of severe pain and complications, and cause considerable social and economic burden of disease. In 2012, herpes zoster vaccine was released in Korea. The efficacy of herpes zoster vaccine is known to be 51.3-66.5% amon...

Descripción completa

Detalles Bibliográficos
Autor principal: Choi, Won Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Vaccine Society 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710929/
https://www.ncbi.nlm.nih.gov/pubmed/23858399
http://dx.doi.org/10.7774/cevr.2013.2.2.92